Prazosin
CHEBI:CHEBI_8364
Definition
A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Chemical Information
- Molecular Formula
- C19H21N5O4
- Molecular Mass
- 383.40110
- Charge
- 0
- SMILES
- COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)c1ccco1
- InChI
- InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)
- InChIKey
- IENZQIKPVFGBNW-UHFFFAOYSA-N
Alternative Names
- 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine
- 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline
- 2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine
- prazosin
- prazosina
- prazosine
- prazosinum
Drug Classification
-
monocarboxylic acid amideView Class →
CHEBI:29347
-
aromatic etherView Class →
CHEBI:35618
-
quinazolinesView Class →
CHEBI:38530
-
furansView Class →
CHEBI:24129
-
t306626
-
t306679
-
t307215
-
piperazinesView Class →
CHEBI:26144
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- oboInOwl#hasDbXref
- Wikipedia:Prazosin
- DRON_00010000
- 8629
- core#notation
- CHEBI:8364
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#hasDbXref
- Wikipedia:Prazosin
- DRON_00010000
- 8629
- oboInOwl#id
- CHEBI:8364
- generic_name
- Prazosin HCL
- brand_name
- Prazosin HCL
- brand_name_base
- Prazosin HCL
- product_ndc
- 63809-2742
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_76779
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- product_type
- BULK INGREDIENT
- dosage_form
- CAPSULE
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- labeler_name
- Bioindustria L.I.M. SpA
- application_number
- ANDA213052
- listing_expiration_date
- 20241231
- marketing_start_date
- 19981006
- spl_id
- fe6a81ad-e1f2-4ad8-9097-964ef8aa57a4
- package_ndc
- 63809-2742-1
- rxcui
- 312594
- manufacturer_name
- Novitium Pharma LLC
- unii
- X0Z7454B90
- spl_set_id
- 4f55f4db-dab3-4e50-9f71-5595fd3ccc12
- package_marketing_start_date
- 20210413
- package_description
- 50 POUCH in 1 BOX (70518-1443-2) / 1 CAPSULE in 1 POUCH (70518-1443-3)
- core#notation
- CHEBI:8364
- route
- ORAL
- active_ingredient_strength
- 35 kg/35kg
- active_ingredient_name
- PRAZOSIN HYDROCHLORIDE
- pharm_class
- alpha-Adrenergic Blocker [EPC]
- upc
- 0368071295139
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- has_treatment
- http://purl.obolibrary.org/obo/DOID_0050936
- owl#annotatedSource
- t307599
- owl#someValuesFrom
- t2990854